Concepedia

Qinxiang Tan

QT

Statistics

Publications

3

Citations

92

H-Index

3

Active since

2021

Affiliations

University of Chinese Academy of Sciences(Current)

Beijing University of Chinese Medicine

Guangzhou University of Chinese Medicine

Southern Medical University

Qinxiang Tan is an author at University of Chinese Academy of Sciences specializing in liver disease, anti-inflammatory activity, and pharmacology.

Publications per year

2021–2024

3

Publications

3

Ginsenoside Rb1 Alleviates Alcohol-Induced Liver Injury by Inhibiting Steatosis, Oxidative Stress, and Inflammation

Yuqi Lai, Qinxiang Tan, Shu Xv et al. · Frontiers in Pharmacology · 2021 · 43 citations · Full text

, , +17

Limonin Alleviates Non-alcoholic Fatty Liver Disease by Reducing Lipid Accumulation, Suppressing Inflammation and Oxidative Stress

Yunjia Li, Menghan Yang, Haiyan Lin et al. · Frontiers in Pharmacology · 2022 · 33 citations · Full text

, , +17

Emodin improves renal fibrosis in chronic kidney disease by regulating mitochondrial homeostasis through the mediation of peroxisome proliferator-activated receptor-gamma coactivator-1 alpha (PGC-1α)

Liuchang Feng, Zaoqiang Lin, Zeyong Tang et al. · European Journal of Histochemistry · 2024 · 16 citations · Full text

, , +16

1–3 of 3